3-Chloro-4-(4-propylpiperazin-1-yl)aniline | 944532-71-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 3-Chloro-4-(4-propylpiperazin-1-yl)aniline
• CAS: 944532-71-2
• 化学式: C₁₃H₂₀ClN₃
• mdl: MFCD07432799
• 分子量: 253.775
• InChiKey: WAIBSPQFSCBTIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  32.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3,5-二氯苯甲酰氯 、 3-Chloro-4-(4-propylpiperazin-1-yl)aniline 在 polymer-supported DIEA 、 polymer-supported trisamine 作用下， 以 二氯甲烷 为溶剂， 生成 3,5-dichloro-N-(3-chloro-4-(4-propylpiperazin-1-yl)phenyl)benzamide
  参考文献：
  名称：

  Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists

  摘要：

  This Letter describes the synthesis and SAR, developed through an iterative analog library approach, of a novel series of selective M-1 mAChR antagonists, based on an N-(4-(4-alkylpiperazin-1-yl)phenyl)benzamide scaffold for the potential treatment of Parkinson's disease, dystonia and other movement disorders. Compounds in this series possess M-1 antagonist IC(50)s in the 350 nM to >10 mu M range with varying degrees of functional selectivity versus M-2-M-5. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.02.041

文献信息

• QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS
  申请人：Bae In Hwan

  公开号：US20130165386A1

  公开（公告）日：2013-06-27

  Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).

  提供的是一种药物组合物，包含一种式子为(I)的喹啉或喹嗪衍生物作为活性成分，以及其药学上可接受的盐、异构体、水合物和溶剂化物。该组合物对于预防和治疗由凋亡抑制蛋白(IAPs)过度表达引起的癌症、炎症、自身免疫性疾病或神经退行性疾病具有有效性。
• US8835458B2
  申请人：——

  公开号：US8835458B2

  公开（公告）日：2014-09-16
• [EN] QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS<br/>[FR] DÉRIVÉS DE QUINOLINE OU DE QUINAZOLINE AYANT UNE ACTIVITÉ INDUISANT L'APOPTOSE SUR LES CELLULES
  申请人：HANMI HOLDINGS CO LTD

  公开号：WO2012030160A2

  公开（公告）日：2012-03-08

  Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).
• Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists
  作者：Nicole R. Miller、R. Nathan Daniels、David Lee、P. Jeffrey Conn、Craig W. Lindsley

  DOI：10.1016/j.bmcl.2010.02.041

  日期：2010.4

  This Letter describes the synthesis and SAR, developed through an iterative analog library approach, of a novel series of selective M-1 mAChR antagonists, based on an N-(4-(4-alkylpiperazin-1-yl)phenyl)benzamide scaffold for the potential treatment of Parkinson's disease, dystonia and other movement disorders. Compounds in this series possess M-1 antagonist IC(50)s in the 350 nM to >10 mu M range with varying degrees of functional selectivity versus M-2-M-5. (C) 2010 Elsevier Ltd. All rights reserved.